The AST commends Dr. Deepali Kumar and Dr. Atul Humar for their recently released article in the New England Journal of Medicine, "A Randomized Trial of Third Dose mRNA-1273 Vaccine in Transplant Recipients." We hope this information will be impactful as both the transplant community and the Federal government consider data-driven next steps related to the value of a third vaccination to enhance protection from severe COVID-19 infection among immunocompromised individuals. Congratulations to Drs. Kumar, Humar and their colleagues on this research effort. The AST will be updating its COVID-19 resources accordingly pending the release of any FDA updates regarding the potential value of third vaccines.